Long-term Follow-up of AAV2-hAQP1 Gene Therapy in Participants with Radiation-Induced Late Xerostomia

This study will assess the long-term safety and efficacy of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.

Study ID: 4368
NCT Number: NCT06544798
Principal Investigator: Patrick Tassone, MD
Department: Otolaryngology
Eligibility: Both men and women 18 years old to 100 years old. Does not accept healthy volunteers.

For questions about this study, please contact:

CancerClinicalTrials@health.missouri.edu